CAROLINA, Puerto Rico, Oct. 17, 2022 /PRNewswire/ -- CorePlus Servicios Clínicos y Patológicos, LLC (CorePlus), a leader in AI-based solutions for cancer detection in pathology, is scaling their expertise in digital pathology to new...

Deep Bio said it signed a partnership with Visiopharm, a Danish pharmaceutical company, to supply DeepDx Prostate, its deep learning-based prostate cancer pathology image analysis software. Under the agreement, Deep Bio will be able to...

In a tongue twister of a collaboration, partners Paige and Perspectum plan to pool pathology tools to progress prospective studies. Both companies are developing artificial intelligence-powered software that analyzes standard tissue...

Seoul, South Korea, and Albuquerque, NM – August 9, 2022 – Deep Bio, a company concentrating on SaMD (Software as a Medical Device) for digital pathology, offering clinically validated, AI-based DeepDx® algorithms, and Indica Labs, a...

Deep Bio: This designation marks the Korean government’s recognition of innovation for DeepDx®-Prostate Pro SEOUL, SOUTH KOREA (PRWEB) JULY 25, 2022 Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics software,...

Ibex: Galen™ Gastric demonstrated outstanding outcomes in detecting gastric cancer in a multi-site study, supporting quality diagnosis, enhanced lab efficiency and quality control Tel Aviv, Israel, June 15, 2022 – Ibex Medical...